Cell-based genotoxicity testing: Genetically modified and genetically engineered bacteria in environmental genotoxicology

Advances in Biochemical Engineering/Biotechnology

Volumn 118, Issue , 2010, Pages 85-112

  Reifferscheid, Georg ^a   Buchinger, Sebastian ^a  

^a FEDERAL INSTITUTE OF HYDROLOGY   (Germany)

Author keywords

Bacterial tester strains; Genotoxicity; Metabolic activation; Mutagenicity; Reportergene assay; SOS response; Xenobiotic metabolism

Indexed keywords

XENOBIOTIC AGENT;

ARTICLE; BACTERIUM; CYTOLOGY; DRUG EFFECT; ENVIRONMENT; GENETIC ENGINEERING; GENETICS; METABOLISM; METHODOLOGY; MUTAGEN TESTING;

BACTERIA; ENVIRONMENT; GENETIC ENGINEERING; MUTAGENICITY TESTS; XENOBIOTICS;

BACTERIA (MICROORGANISMS); RODENTIA; SALMONELLA;

EID: 77955520159     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2009_8     Document Type: Article

References (121)

1. OECD (1997) Bacterial reverse mutation test. Guideline for Testing of Chemicals 471. OECD, Paris.
2. Müller L, Kikuchi Y, Probst G, Schechtman L, Shimada H, Sofuni T, Tweats D (1999) ICH-Harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat Res 436(3):195-225.
3. OSPAR Commission (2002) Survey on genotoxicity test methods for the evaluation of waste water within whole effluent assessment. OSPAR, London, UK.
4. ISO (2000) Water quality - determination of the genotoxicity of water and waste water using the umu-test. ISO 13829, ISO, Geneva
5. ISO (2005) Water quality - determination of the genotoxicity of water and waste water - Salmonella/microsome test (Ames test). ISO 16240, ISO, Geneva
6. International Conference on Harmonization (1997) Guidance for industry. S2B genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals. Brussels, Belgium, March 1997
7. Hartman PE, Hartman Z, Stahl RC (1971) Classification and mapping of spontaneous and induced mutations in the histidine operon of Salmonella. Adv Genet 16:1-34.
8. Ames BN, Gurney EG, Miller JA, Bartsch H (1972) Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc Natl Acad Sci U S A 69(11):3128-3132.
9. Ames BN, Durston WE, Yamasaki E, Lee FD (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A 70(8):2281-2285.
10. McCann J, Ames BN (1976) Detection of carcinogens as mutagens in the Salmonella /microsome test: assay of 300 chemicals: discussion. Proc Natl Acad Sci U S A 73 (3): 950-954.
11. Jurado J, Alejandre-Durán E, Pueyo C (1993) Genetic differences between the standard Ames tester strains TA100 and TA98. Mutagenesis. 8(6):527-32.
12. McCann J, Spingarn NE, Kobori J, Ames BN (1975) Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc Natl Acad Sci U S A 72(3):979-983.
13. Mortelmans K (2006) Isolation of plasmid pKM101 in the Stocker laboratory. Mutat Res 612(3):151-164.
14. Cebula TA, Koch WH (1990) Sequence analysis of Salmonella typhimurium revertants. Prog Clin Biol Res. 340D:367-77. Review.
15. Hartman PE, Ames BN, Roth JR, Barnes WM, Levin DE (1986) Target sequences formuta-genesis in Salmonella histidine-requiring mutants. Environ Mutagen 8(4):631-641.
16. Walker GC (1977) Plasmid (pKM101)-mediated enhancement of repair and mutagenesis: dependence on chromosomal genes in Escherichia coli K-12. Mol Gen Genet 152 (1): 93-103.
17. Marsh L, Walker GC (1987) New phenotypes associated with mucAB: alteration of a MucA sequence homologous to the LexA cleavage site. J Bacteriol 169(5):1818-1823.
18. Perry KL, Elledge SJ, Mitchell BB, Marsh L, Walker GC (1985) umuDC and mucAB operons whose products are required for UV light- and chemical-induced mutagenesis: UmuD, MucA, and LexA proteins share homology. Proc Natl Acad Sci U S A 82(13):4331-4335.
19. Levin DE, Hollstein M, Christman MF, Schwiers EA, Ames BN (1982) A new Salmonella tester strain (TA102) with A:T base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci U S A 79(23):7445-7449.
20. Albertini S, Gocke E (1988) Plasmid copy number and mutant frequencies in S. typhimurium TA102. Environ Mol Mutagen 12(4):353-363.
21. Levin DE, Yamasaki E, Ames BN (1982) A new Salmonella tester strain, TA97, for the detec- tion of frameshift mutagens. A run of cytosines as a mutational hot-spot. Mutat Res 94(2): 315-330.
22. Bridges BA, Dennis RE, Munson RJ (1967) Differential induction and repair of ultraviolet damage leading to true revesions and external suppressor mutations of an ochre codon in Escherichia coli B-r WP2. Genetics 57(4):897-908.
23. Venturini S, Monti-Bragadin C (1978) R plasmid-mediated enhancement of mutagenesis in strains of Escherichia coli deficient is known repair functions. Mutat Res 50(1):1-8.
24. Prival MJ, King VD, Sheldon AT Jr (1979) The mutagenicity of dialkyl nitrosamines in the Salmonella plate assay. Environ Mutagen 1(2):95-104.
25. Agurell E, Stensman C (1992) Salmonella mutagenicity of three complex mixtures assayed with the microsuspension technique. A WHO/IPCS/CSCM study. Mutat Res 276(1/2): 87-91.
26. Bagley ST, Stoltz SL, Becker DM, Keen RE (1992) Characterization of organic extracts from standard reference materials 1649, 'urban dust/organics,' and 1650, 'diesel particulate matter', using a microsuspension assay. A WHO/IPCS/CSCM study. Mutat Res 276(1/2):81-86.
27. Azuma S, Kishino S, Katayama S, Akahori Y, Matsushita H (1997) Highly sensitive mutation assay for mutagenicity monitoring of indoor air using Salmonella typhimurium YG1041 and a microsuspension method. Mutagenesis 12(5):373-377.
28. Gatehouse DG, Paes DJ (1983) A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction. Carcinogenesis 4(3):347-352.
29. Flückiger-Isler S, Baumeister M, Braun K, Gervais V, Hasler-Nguyen N, Reimann R, Van Gompel J, Wunderlich HG, Engelhardt G (2004) Assessment of the performance of the Ames II assay: a collaborative study with 19 coded compounds. Mutat Res 558(1/2):181-197.
30. Reifferscheid G, Arndt C, Schmid C (2005) Further development of the beta-lactamase MutaGen assay and evaluation by comparison with Ames fluctuation tests and the umu test. Environ Mol Mutagen 46(2):126-139.
31. Gee P, Maron DM, Ames BN (1994) Detection and classification of mutagens: a set of base-specific Salmonella tester strains. Proc Natl Acad Sci U S A 91(24):11606-11610.
32. Cupples CG, Miller JH (1989) A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions. Proc Natl Acad Sci U S A 86(14):5345-5349.
33. Miller JE, Vlasakova K, Glaab WE, Skopek TR (2005) A low volume, high-throughput forward mutation assay in Salmonella typhimurium based on fluorouracil resistance. Mutat Res 578(1/2):210-224.
34. Dorado G, Pueyo C, (1988) L-Arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening. Cancer Res 48(4):907-912.
35. Schmid C, Arndt C, Reifferscheid G (2003) Mutagenicity test system based on a reporter gene assay for short-term detection of mutagens (MutaGen assay). Mutat Res 535(1):55-72.
36. Tomasz A (1979) From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view. Rev Infect Dis 1(3):434-467.
37. Tomasz A (1979) The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol 33:113-137.
38. Hillen W, Berens C (1994) Mechanisms underlying expression of TN10 encoded tetracycline resistance. Annu Rev Microbiol 48:345-369.
39. Degenkolb J, Takahashi M, Ellestad GA, Hillen W (1991) Structural requirements of tetracycline- tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the tet repressor. Antimicrob Agents Chemother 35: 1591-1595.
40. Radman M (1975) SOS repair hypothesis: phenomenology of an inducible DNA repair which is accompanied by mutagenesis. Basic Life Sci 5A:355-367.
41. Brent R, Ptashne M (1980) The lexA gene product represses its own promoter. Proc Natl Acad Sci U S A 77(4):1932-1936.
42. Little JW, Mount DW, Yanisch-Perron CR (1981) Purified lexA protein is a repressor of the recA and lexA genes. Proc Natl Acad Sci U S A 78(7):4199-4203.
43. Little JW (1983) The SOS regulatory system: control of its state by the level of RecA protease. J Mol Biol 167(4):791-808.
44. Little JW, Edmiston SH, Pacelli LZ, Mount DW (1980) Cleavage of the Escherichia coli lexA protein by the recA protease. Proc Natl Acad Sci U S A 77(6):3225-3229.
45. Giese KC, Michalowski CB, Little JW (2008) RecA-dependent cleavage of LexA dimers. J Mol Biol 377(1):148-161.
46. Huisman O, D'Ari R, George J (1980) Further characterization of sfiA and sfiB mutations in Escherichia coli. J Bacteriol 144(1):185-191.
47. Schendel PF, Fogliano M, Strausbaugh LD (1982) Regulation of the Escherichia coli K-12 uvrB operon. J Bacteriol 150(2):676-685.
48. Frey J, Ghersa P, Palacios PG, Belet M (1986) Physical and genetic analysis of the ColD plasmid. J Bacteriol. 166(1):15-9.
49. Tomita K, Ogawa T, Uozumi T, Watanabe K, Masaki H (2000) A cytotoxic ribonuclease which specifically cleaves four isoaccepting arginine tRNAs at their anticodon loops. Proc Natl Acad Sci U S A 97 (15): 8278-8283.
50. de Zamaroczy M, Mora L, Lecuyer A, Géli V, Buckingham RH (2001) Cleavage of colicin D is necessary for cell killing and requires the inner membrane peptidase LepB. Mol Cell 8 (1): 159-168.
51. Quillardet P, Huisman O, D'Ari R, Hofnung M (1982) SOS chromotest, a direct assay of induction of an SOS function in Escherichia coli K-12 to measure genotoxicity. Proc Natl Acad Sci U S A 79(19):5971-5975.
52. Oda Y, Nakamura S, Oki I, Kato T, Shinagawa H (1985) Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res 147 (5): 219-229.
53. Ptitsyn LR, Horneck G, Komova O, Kozubek S, Krasavin EA, Bonev M, Rettberg P (1997) A biosensor for environmental genotoxin screening based on an SOS lux assay in recombinant Escherichia coli cells. Appl Environ Microbiol. 63(11):4377-84.
54. Norman A, Hestbjerg Hansen L, Sørensen SJ (2005) Construction of a ColD cda promoter-based SOS-green fluorescent protein whole-cell biosensor with higher sensitivity toward genotoxic compounds than constructs based on recA, umuDC, or sulA promoters. Appl Environ Microbiol 71 (5): 2338-2346.
55. Nunoshiba T, Nishioka H, (1991) 'Rec-lac test' for detecting SOS-inducing activity of environ- mental genotoxic substance. Mutat Res 254 (1): 71-77.
56. Verschaeve L, Van Gompel J, Thilemans L, Regniers L, Vanparys P, van der Lelie D (1999) VITOTOX bacterial genotoxicity and toxicity test for the rapid screening of chemicals. Environ Mol Mutagen 33 (3): 240-248.
57. Vollmer AC, Belkin S, Smulski DR, Van Dyk TK, LaRossa RA (1997) Detection of DNA damage by use of Escherichia coli carrying recA'::lux, uvrA'::lux or alkA'::lux reporter plasmids. Appl Environ Microbiol 63: 2566-2571.
58. Davidov Y, Rozen R, Smulski DR, van Dyk TK, Vollmer AC, Elsemore DA, LaRossa RA, Belkin S (2000) Improved bacterial SOS promoter: lux fusions for genotoxicity detection. Mutat Res 466:97-107.
59. Chalfie M, Tu G, Euskirchen G, Ward WW, Prasher DC (1994) Green fluorescent protein as a marker for gene expression. Science 263:802-804.
60. Crameri A, Whitehorn EA, Tate E, Stemmer WPC (1996) Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol 14:315-319.
61. Arkady FF, Ying C, Li D, Ekaterina VB, Mikhail VM, Sergey AL (2000) Novel fluorescent protein from Discosoma coral and its mutants possesses a unique far-red fluorescence. FEBS Lett 479:127-130.
62. Shaner NC, Patterson GH, Davidson MW (2007) Advances in fluorescent protein technology. J Cell Sci 120:4247-4260.
63. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A (2002) A variant of yellow fluo- rescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90.
64. Blokpoel MC, O'Toole R, Smeulders MJ, Williams HD (2003) Development and application of unstable GFP variants to kinetic studies of mycobacterial gene expression. J Microbiol Methods 54: 203-211.
65. Justus T, Thomas SM (1999) Evaluation of transcriptional fusions with green fluorescent protein versus luciferase as reporters in bacterial mutagenicity tests. Mutagenesis 14: 351-356.
66. Arai R, Makita Y, Oda Y, Nagamune T (2001) Construction of green fluorescent protein reporter genes for genotoxicity test (SOS/ umu-test) and improvement of mutagen-sensitivity. J Biosci Bioeng 92:301-304.
67. Kostrzynska M, Leung KT, Lee H, Trevors JT (2002) Green fluorescent protein-based biosensor for detecting SOS-inducing activity of genotoxic compounds. J Microbiol Methods 48: 43-51.
68. Sagi E, Hever N, Rosen R, Bartolome AJ, Rajan Premkumar J, Ulber R, Lev O, Scheper T, Belkin S (2003) Fluorescence and bioluminescence reporter functions in genetically modified bacterial sensor strains. Sens Actuators B Chem 90:2-8.
69. Hakkila K, Maksimow M, Karp M, Virta M (2002) Reporter genes lucFF, luxCDABE, gfp, and dsred have different characteristics in whole-cell bacterial sensors. Anal Biochem 301: 235-242.
70. Norman A, Hansen LH, Sorensen SJ (2006) A flow cytometry-optimized assay using an SOS-green fluorescent protein (SOS-GFP) whole-cell biosensor for the detection of genotoxins in complex environments. Mutat Res 603(2):164-172.
71. Ostergaard TG, Hansen LH, Binderup ML, Norman A, Sørensen SJ (2007) The cda GenoTox assay: a new and sensitive method for detection of environmental genotoxins, including nitroarenes and aromatic amines. Mutat Res 631 (2): 77-84.
72. von der Hude W, Behm C, Gürtler R, Basler A (1988) Evaluation of the SOS chromotest. Mutat Res 203(2):81-94.
73. Dipple A (1995) DNA adducts of chemical carcinogens. Carcinogenesis 16(3):437-441.
74. Seidegard J, Ekstrom G, (1997) The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105(4):791-799.
75. Kranendonk M, Laires A, Rueff J, Estabrook WR, Vermeulen NP, (2000) Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations. Crit Rev Toxicol 30: 287-306.
76. Shimada T, Yamazaki H, Oda Y, Hiratsuka A, Watabe T, Guengerich FP (1996) Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S -transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem Res Toxicol 9: 333-340.
77. Martignoni M, Groothuis GM, de Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2(6):875-894.
78. Gundert-Remy U, Sonich-Mullin C (2002) IPCS uncertainty and variability planning workgroup and drafting group (International program on chemical safetys). The use of toxicokinetic and toxi-codynamic data in risk assessment: an international perspective. Sci Total Environ 288 (1/2): 3-11.
79. Malling HV (1967) The mutagenicity of the acridine mustard (ICR-170) and the structurally related compounds in Neurospora. Mutat Res 4(3):265-274.
80. Glatt H (1997) Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation. FASEB J 11(5):314-321.
81. Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8(1):101-111.
82. Roberts GA, Grogan G, Greter A, Flitsch SL, Turner NJ (2002) Identification of a new class of cytochrome P450 from a Rhodococcus sp. J Bacteriol 184(14):3898-3908.
83. Agematu H, Matsumoto N, Fujii Y, Kabumoto H, Doi S, Machida K, Ishikawa J, Arisawa A (2006) Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci Biotechnol Biochem 70(1):307-311.
84. Dong J, Porter TD (1996) Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli. Arch Biochem Biophys 327 (2): 254-259.
85. Blake JA, Pritchard M, Ding S, Smith GC, Burchell B, Wolf CR, Friedberg T (1996) Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli. FEBS Lett 397(2/3):210-214.
86. Shet MS, Fisher CW, Estabrook RW (1997) The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17 alpha-hydroxylation of progesterone and pregnenolone by P450c17. Arch Biochem Biophys 339 (1): 218-225.
87. Parikh A, Gillam EM, Guengerich FP (1997) Drug metabolism by Escherichia coli express- ing human cytochromes P450. Nat Biotechnol 15(8):784-788.
88. Emmert B, Bünger J, Keuch K, Müller M, Emmert S, Hallier E, Westphal GA (2006) Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic com- petent S. typhimurium strain YG7108pin3ERb5. Toxicology 228(1):66-76.
89. Aryal P, Yoshikawa K, Terashita T, Guengerich FP, Shimada T, Oda Y (1999) Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase. Mutat Res 442(2):113-120.
90. Oda Y, Aryal P, Terashita T, Gillam EM, Guengerich FP, Shimada T (2001) Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O -acetyltransferase. Mutat Res 492 (1/2): 81-90.
91. Aryal P, Terashita T, Guengerich FP, Shimada T, Oda Y (2000) Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/ umu assay. Environ Mol Mutagen 36 (2): 121-126.
92. Sugimura T (1997) Overview of carcinogenic heterocyclic amines. Mutat Res 376 (1/2): 211-219.
93. Kataoka H (1997) Methods for the determination of mutagenic heterocyclic amines and their applications in environmental analysis. J Chromatogr A 774(1/2):121-142.
94. Oda Y, Shimada T, Watanabe M, Ishidate M Jr, Nohmi T (1992) A sensitive umu test system for the detection of mutagenic nitroarenes in Salmonella typhimurium NM1011 having a high nitroreductase activity. Mutat Res 272(2):91-99.
95. Oda Y, Yamazaki H, Watanabe M, Nohmi T, Shimada T (1995) Development of high sensitive umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity. Mutat Res 334 (2): 145-156.
96. Oda Y, Yamazaki H, Shimada T (1999) Role of human N -acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium NM6001 and NM6002. Carcinogenesis 20(6):1079-1083.
97. Oda Y, Yamazaki H, Thier R, Ketterer B, Guengerich FP, Shimada T (1996) A new Salmonella typhimurium NM5004 strain expressing rat glutathione S-transferase 5-5: use in detection of genotoxicity of dihaloalkanes using an SOS/ umu test system. Carcinogenesis 17(2):297-302.
98. Watanabe M, Ishidate M Jr, Nohmi T (1989) A sensitive method for the detection of muta-genic nitroarenes: construction of nitroreductase-overproducing derivatives of Salmonella typhimurium strains TA98 and TA100. Mutat Res 216(4):211-220.
99. Watanabe M, Ishidate M Jr, Nohmi T (1990) Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutat Res 234(5):337-348.
100. Hagiwara Y, Watanabe M, Oda Y, Sofuni T, Nohmi T (1993) Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possessing elevated levels of both nitroreductase and acetyltransferase activity. Mutat Res 291(3):171-180.
101. Chasseaud LF (1997) The role of glutathione ans glutathione transferases in the metabolism of chemical carcinogens and other electrophilic reagents. Adv Cancer Res 29:175-274.
102. Coles B, Ketterer B (1990) The role of glutathione and glutathione transfersase in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25:47-70.
103. Decant W, Vamvakas S, Anders MW (1989) Bioactivation of nephrotoxic haloalkenes by glutathiuone conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate ß-lyase. Drug Metab Rev 20: 43-83.
104. Monks TJ, Lau SS (1994) Glutathione conjugate mediated toxicities. In: Kauffman FC (ed) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 459-509.
105. Thier R, Taylor JB, Pemble SE, Humphreys WG, Persmark M, Ketterer B, Guengerich FP (1993) Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc Natl Acad Sci USA 90(18):8576-8580.
106. Guengerich FP, Wheeler JB, Chun YJ, Kim D, Shimada T, Aryal P, Oda Y, Gillam EM (2002) Use of beterologously-expressed cytochrome P450 and glutathione transferase enzymes in toxicity assays. Toxicology 181-182:261-4.
107. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characteriza- tion of a genetic polymorphism. Biochem J 300(1):271-276.
108. Yamazaki H, Oda Y, Shimada T (1992) Use of a newly developed tester strain Salmonella typhimurium NM2009 for the study of metabolic activation of carcinogenic aromatic amines by rat liver microsomal cytochrome P-450 enzymes. Mutat Res 272 (2): 183-192.
109. Lotlikar PD, Hong YS (1981) Microsomal N- and C-oxidations of carcinogenic aromatic amines and amides. Natl Cancer Inst Monogr 58:101-107.
110. McCoy EC, Anders M, Rosenkranz HS (1983) The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP6 to the mutagenic action of nitroarenes. Mutat Res 121 (1): 17-23.
111. Heflich RH, Djuri Z, Zhuo Z, Fullerton NF, Casciano DA, Beland FA (1988) Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay. Environ Mol Mutagen 11 (2): 167-181.
112. Lower GM Jr, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryan GT (1979) N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect 29: 71-79.
113. Lang NP, Chu DZ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121 (11): 1259-1261.
114. Glatt H, Meinl W (2005) Sulfotransferases and acetyltransferases in mutagenicity testing: technical aspects. Methods Enzymol 400:230-249.
115. Miller JA, Surh YJ (1994) Sulfonation in chemical carcinogenes. In: Kauffman FC (ed) Handbook of pharmacology, vol 112: Conjugation-deconjugation reactions in drug metabolism and toxicity. Springer, Berlin Heidelberg New York, pp 429-458.
116. Suzuki H, Morris JS, Li Y, Doll MA, Hein DW, Liu J, Jiao L, Hassan MM, Day RS, Bondy ML, Abbruzzese JL, Li D (2008) Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 29(6):1184-1191.
117. Glatt H (2005) Activation and inactivation of carcinogens by human sulfotransferases. In: Pacifici GM, Coughtrie MWH (eds) Human sulfotransferases. Taylor & Francis, London.
118. Glatt H, Meinl W (2004) Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Carcinogenesis 25 (5): 779-786.
119. Tokiwa H, Ohnishi Y (1986) Mutagenicity and carcinogenicity of nitroarenes and their sources in the environment. Crit Rev Toxicol 17(1):23-60.
120. Wild D (1990) A novel pathway to the ultimate mutagens of aromatic amino and nitro compounds. Environ Health Perspect 88: 27-31.
121. Oda Y, Yamazaki H, Watanabe M, Nohmi T, Shimada T (1993) Highly sensitive umu test system for the detection of mutagenic nitroarenes in Salmonella typhimurium NM3009 having high O -acetyltransferase and nitroreductase activities. Environ Mol Mutagen 21 (4): 357-364.